Home › Funds › Campbell & CO Investment Adviser LLC › CRSP
Campbell & CO Investment Adviser LLC position in CRSP
CRISPR THERAPEUTICS AG · Health Care
Campbell & CO Investment Adviser LLC reported holding 107,529 shares of CRSP (CRISPR THERAPEUTICS AG) in its Q2 2026 13F filing — a position valued at US$5.9M, representing 0.31% of its reported portfolio and ranking #48 among its reported holdings. Campbell & CO Investment Adviser LLC has disclosed CRSP holdings in 4 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Campbell & CO Investment Adviser LLC's CRSP position evolved
Campbell & CO Investment Adviser LLC first disclosed a stake in CRSP in Q4 2023 at 18,774 shares (US$1.2M). The position peaked in Q2 2026 at 107,529 shares, worth US$5.9M. Across 4 filings, Campbell & CO Investment Adviser LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 107,529 shares valued at US$5.9M. Notable position changes include a 52% trim in Q1 2024 (shares fell 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 18.77K | $1.18M | New |
| Q1 2024 | 8.92K | $607.85K | Reduce |
| Q3 2024 | 18.32K | $860.77K | New |
| Q2 2026 | 107.53K | $5.86M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRSP and 13F data
CRSP (CRISPR THERAPEUTICS AG) is a Health Care company. 32 other funds we track also report a position in CRSP — the largest reported positions include ARK Invest (US$516.0M), Orbis Allan Gray Ltd (US$297.2M), GSK plc (US$175.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRSP
- ARK Invest 9.46M sh · $516.00M · Q2 2026
- Orbis Allan Gray Ltd 5.45M sh · $297.20M · Q2 2026
- GSK plc 3.22M sh · $175.65M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 2.04M sh · $111.19M · Q2 2026
- Amova Asset Management Americas, Inc. 1.72M sh · $93.76M · Q2 2026
- EcoR1 Capital, LLC 1.39M sh · $75.77M · Q2 2026
- NEA Management Company, LLC 1.06M sh · $57.73M · Q2 2026
More on Campbell & CO Investment Adviser LLC
FAQ
How long has Campbell & CO Investment Adviser LLC held CRSP?
Campbell & CO Investment Adviser LLC has disclosed CRSP holdings in 4 of the last 11 reported quarters, going back to Q4 2023.
What is Campbell & CO Investment Adviser LLC's current position in CRSP?
As of Q2 2026, Campbell & CO Investment Adviser LLC holds 107.53K shares of CRSP (CRISPR THERAPEUTICS AG), valued at $5.86M, representing 0.31% of its reported portfolio and ranking #48.
Has Campbell & CO Investment Adviser LLC been buying or selling CRSP?
In the latest 13F filing (Q2 2026), Campbell & CO Investment Adviser LLC newly opened its position in CRSP. The position peaked in Q2 2026 at 107.53K shares.
Which other funds hold CRSP?
Other major institutional holders of CRSP include ARK Invest, Orbis Allan Gray Ltd, GSK plc, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.